Portfolio / Alesta

Alesta Therapeutics, a biotechnology company founded in Leiden in 2021, is developing novel small molecules to treat genetically defined tRNA disorders, with an initial focus on Charcot-Marie-Tooth (CMT) disease.

Click here to read the Impact Story of Alesta.

Company: Alesta
Fund: III
Status: Active
Team member: Michel Briejer
Technology: Therapeutics